| Heading: |
Cancer: Drugs |
| Question ID: |
1813604 |
| UIN: |
60695 |
| House: |
Commons |
| Date tabled: |
2025-06-17 |
| Asking Member ID: |
5207 |
| Asking Member display name: |
Clive Jones
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Clive Jones
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the availability of availability of cancer drugs is maintained during the reorganisation of NHS England. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-26 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Whilst this transformation takes place, we will ensure that we continue to evaluate impacts of all kinds and will work collaboratively to ensure continuity of care and that there are no risks to patient safety. Throughout the organisational change, NHS En... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |